Hanall Biopharma Co.,Ltd
KRX:009420.KS
44950 (KRW) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||
| Net Income
| 3,508.608 | 251.474 | 8,896.137 | 19,764.499 | 19,174.35 | 3,300.102 | 5,813.254 | 2,026.026 | -7,077.357 | -12,658.085 | -21,498.897 | -2,922.595 | -14,525.74 | 213.659 | 581.952 | 1,170.025 | -1,029.708 |
| Depreciation & Amortization
| 3,246.945 | 3,052.653 | 2,724.857 | 2,894.219 | 2,715.07 | 1,989.487 | 2,162.022 | 2,234.664 | 2,316.946 | 2,260.182 | 1,952.06 | 1,715.461 | 1,800.006 | 1,987.147 | 2,598.981 | 2,984.192 | 2,198.01 |
| Deferred Income Tax
| -2,723.482 | 0 | 3,538.481 | -6,987.918 | 4,264.499 | 10,139.057 | 3,023.237 | 3,624.886 | 4,249.839 | 14,665.231 | 8,031.459 | -1,822.053 | 5,026.726 | 4,436.619 | 3,235.688 | 626.015 | 3,688.805 |
| Stock Based Compensation
| 1,623.209 | 1,874.724 | 1,616.637 | 794.302 | 507.675 | 561.273 | 29.345 | 193.599 | 216.714 | 270.798 | 273.171 | 683.681 | 515.136 | 390.469 | 276.035 | 298.822 | 114.007 |
| Change In Working Capital
| 20,182.878 | 14,854.598 | -15,241.055 | -13,406.781 | -4,060.392 | -17,153.561 | 32,758.958 | -2,489.24 | 1,927.294 | -6,875.944 | 2,074.218 | 4,666.758 | 12,190.916 | -6,369.417 | -2,255.339 | -8,466.777 | -4,733.795 |
| Accounts Receivables
| 8,167.764 | -2,465.701 | -5,086.593 | 8,180.133 | -914.046 | 1,439.28 | 3,538.766 | 765.457 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -8,291.72 | -5,814.409 | -1,475.604 | -8,435.101 | 189.787 | -1,399.627 | 405.868 | 1,365.789 | -1,585.969 | -823.772 | -1,221.178 | -2,543.089 | 5,032.989 | -778.639 | -4,540.714 | -3,325.739 | -2,458.406 |
| Accounts Payables
| 5,517.573 | 3,360.537 | -3,187.023 | 646.626 | 1,469.752 | -2,130.386 | -1,552.873 | 1,698.212 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 14,789.261 | 19,774.171 | -5,491.835 | -13,798.439 | -4,805.885 | -15,753.934 | 32,353.09 | -3,855.029 | 3,513.263 | -6,052.172 | 3,295.396 | 7,209.847 | 7,157.927 | -5,590.778 | 2,285.375 | -5,141.038 | -2,275.389 |
| Other Non Cash Items
| 3,804.763 | 5,170.902 | -695.185 | -2,129.03 | -2,110.283 | -1,830.75 | -1,648.164 | -1,639.567 | -2,087.46 | -1,180.539 | 1,387.89 | -124.086 | 2,406.937 | 760.304 | 304.861 | 109.071 | 34.403 |
| Operating Cash Flow
| 29,642.92 | 25,204.351 | 839.872 | 929.291 | 20,490.919 | -2,994.392 | 42,138.652 | 3,950.368 | -454.024 | -3,518.357 | -7,780.099 | 2,197.166 | 7,413.981 | 1,418.781 | 4,742.178 | -3,278.652 | 271.722 |
| Investing Activities: | |||||||||||||||||
| Investments In Property Plant And Equipment
| -9,197.667 | -7,676.957 | -9,002.097 | -7,389.646 | -8,275.831 | -1,918.921 | -2,208.034 | -4,031.562 | -3,346.553 | -3,600.473 | -6,563.981 | -6,992.751 | -6,456.177 | -12,278.599 | -10,096.882 | -10,338.461 | -6,958.945 |
| Acquisitions Net
| -1,000 | 17 | -570.549 | -4,825.822 | 9.342 | 7.904 | -170.749 | -817.415 | -1,191.965 | -2,325.653 | 36.207 | -4,801.868 | 5,595.386 | -8,529.507 | -5,147.357 | -3,128.679 | -225.247 |
| Purchases Of Investments
| -2,679.1 | -2,933.03 | 4,396.194 | -30 | -28,330.361 | -14,626.97 | -9,653.17 | -8,554.055 | -39,898.159 | -6,267.398 | -8,184.301 | -23,950 | -11,429.8 | -12,754.356 | -8,624.333 | -20,551.548 | -14,371.927 |
| Sales Maturities Of Investments
| 1,000 | 0.548 | 17,481.4 | 5,100.411 | -9.342 | 428.096 | 1,499.3 | 1,556 | 6,757.398 | 8,028.12 | 25,760 | 8,367.3 | 11,609.8 | 12,271.027 | 9,764.827 | 21,324.472 | 14,100.393 |
| Other Investing Activites
| -10.463 | 0 | -4,275.285 | 4,827.322 | 9.342 | -0 | 480.999 | 1,043.59 | 1,363.284 | 2,330.653 | 39.948 | 6,853.392 | 6,029.475 | 8,560.924 | 5,182.634 | 2,529.959 | -89.6 |
| Investing Cash Flow
| -11,887.229 | -10,592.439 | 8,029.663 | -2,317.735 | -36,596.85 | -16,109.891 | -10,051.654 | -10,803.442 | -36,315.997 | -1,834.751 | 11,087.873 | -20,523.927 | 5,348.684 | -12,730.511 | -8,921.111 | -10,164.257 | -7,545.326 |
| Financing Activities: | |||||||||||||||||
| Debt Repayment
| -813.508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29,594.398 | -4,613.519 | -15,384.44 | -31,691.687 | -32,923.077 | -16,859.102 | -20,167.296 | -10,560.926 | -12,086.231 |
| Common Stock Issued
| 0 | 59.862 | 408.716 | 68.328 | 0 | 0 | 592.73 | 7,062.998 | 58,674.335 | 0 | 3,803.396 | 30,152.995 | 1,067.5 | 432.451 | 271.7 | 0 | 74.466 |
| Common Stock Repurchased
| 0 | -10,005.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,143.979 | -2,835.471 | 0 | 0 | 0 | 0 | -1,001.324 | 17,931.987 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -343.021 |
| Other Financing Activities
| -813.508 | -698.877 | -715.249 | -587.673 | 0 | 0 | 0 | 0 | 9,400 | 7,527.722 | 8,560.39 | 21,355.036 | 27,462.861 | 16,538.144 | 29,883.2 | 26,522.1 | 0.001 |
| Financing Cash Flow
| -813.508 | -10,644.037 | -306.533 | -519.345 | -459.599 | -0 | 592.73 | 7,062.998 | 38,479.937 | 1,770.224 | -10,136.321 | 19,816.344 | -4,392.716 | 111.493 | 9,987.604 | 14,959.85 | 5,577.202 |
| Other Information: | |||||||||||||||||
| Effect Of Forex Changes On Cash
| -60.451 | 78.634 | 30.854 | -11.849 | 3.192 | -135.596 | -256.492 | 1.457 | 14.977 | 11.174 | -60.932 | -45.98 | 28.562 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 16,881.731 | 4,046.509 | 8,593.856 | -1,919.639 | -16,562.338 | -19,239.88 | 32,423.236 | 211.381 | 1,724.894 | -3,571.71 | -6,889.479 | 1,443.603 | 8,398.511 | -11,200.237 | 5,808.671 | 1,516.941 | -1,696.402 |
| Cash At End Of Period
| 33,722.514 | 16,840.782 | 12,794.274 | 4,200.417 | 6,120.056 | 22,682.394 | 41,922.274 | 9,499.038 | 9,287.657 | 7,562.763 | 11,134.474 | 18,023.953 | 16,580.35 | 8,033.006 | 19,233.243 | 13,424.572 | 11,907.631 |